Peer Review History
| Original SubmissionNovember 15, 2021 |
|---|
|
PONE-D-21-36330Testing the effectiveness of alcohol health warning label formats: An online experimental study with Australian adult drinkersPLOS ONE Dear Dr. Brennan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 30 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Rafael Aiello Bomfim, Phd Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please amend your current ethics statement to address the following concerns: a) Did participants provide their written or verbal informed consent to participate in this study? b) If consent was verbal, please explain i) why written consent was not obtained, ii) how you documented participant consent, and iii) whether the ethics committees/IRB approved this consent procedure. 3. Thank you for stating the following in the Competing Interests section: “I have read the journal’s policy and the authors of this manuscript have the following competing interests: EB, KD, AV, SD and MW are employed by a non-profit organisation that conducts research, public health interventions and advocacy aimed at reducing alcohol-related health harms in the community, especially those pertaining to cancer. EB, SP and MW have received other NHMRC grants on alcohol harm communication. EB is a member of the Expert Reference Group for the Alcohol.Think Again campaign. JH has provided advice to Alcohol Healthwatch, a New Zealand non-profit organisation that conducts advocacy to reduce alcohol-related health harms in the community. SP is a Board Member of the Foundation for Alcohol Research and Education, and a member of government advisory committees on alcohol.” Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: ""This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf. 4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. Additional Editor Comments: there are some points that deserve attention as pointed out by the reviewer. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This study aims to experimentally test the effects of alcohol container health warning labels varying by label format and health message versus control labels with no or an industry-developed warning among Australian adult alcohol consumers. This is a well-designed and carefully executed RCT, I particularly applaud the innovative approach for testing label effects immediately following label exposure as well as after 8 days of label exposure. Minor suggestions and questions to consider are listed below. Introduction Line 70: I am not familiar with the term “textual”, would you consider “weak message content, and most lack images”? Line 71: Is there value in adding an example of a situation harm that allow most drinkers to self-exempt (e.g., drinking when pregnant)? Line 71: Please note that South Korea mandates 1 or 3 HWL on alcohol containers, including 1 label with a cancer warning. However, industry selects which 1 of the 3 labels to use. Moreover, although Ireland has passed legislation mandated HWL with a cancer message, it has not yet been implemented due to a pause caused by industry pushback. At a minimum, please add a statement about the unprecedented pause in implementing the label regulations in Ireland. Line 75: How long has DrinkWise Australia been voluntarily using labels on alcohol containers? Was this a new initiative in 2020? Line 78: Please add: “a pregnancy HWL on all alcohol containers, with a minimum size requirement and a white background….”. Line 85: Given that any amount of alcohol increases cancer risk, what is the definition of “risky alcohol consumption”? I suggest revising this statement by removing “risky”. Line 88: Is this 50% of the front of the package or 50% of the entire tobacco package? Line 88: Please add “full colour” before “image and covering at least 50% of the package”. Is it also worth highlighting the efficacy of rotating messages on tobacco HWL to reduce message wear out? Line 102: Please update this statement to read: “educating about the number of standard drinks in a container”. Line 102: The labels in the Yukon study were not placed on the front of the container – but somewhere on the container to avoid overlapping with industry labels. Line 103: The usual practice at the 2 control liquor stores included a long-standing label warning about drinking when pregnant, when operating a car or machinery, and general health risks. Lines 104 – 107: As described in the scoping review by Kokole et al., 2021, the Yukon labelling study was designed based on the theory that exposure to well-designed labels over time can increase attention to and deep cognitive processing of label information, leading to increased knowledge of alcohol-related harms and behaviour change. Whereas most lab-based labelling studies are largely focused on an immediate reaction after a one-time exposure to labels. Line 109: This sentence is awkward, please revise. Pictorial, image, and photograph are used interchangeably throughout the Introduction. This is ok but I wanted to raise to ensure it is intentional. Lines 114-115: Revise to “a range of relatively lesser known alcohol-related chronic health harms”. Methods Lines 126-128: Use #s instead of letters to list the 5 conditions. Lines 128-129: Revise to: “In each of the three intervention label conditions, participants were exposed to eight HWLs depicting a different alcohol-related health harm.” Lines 133-136: Why was power calculation based on the outcome, intentions to limit to drinking? What was the 30% attrition rate based on? Line 156: Is 18 years the minimum legal drinking age in Australia? If yes, please indicate so. Lines 176-177: Was the order participants were exposed to the 8 HWLs randomized? Why were the 8 HWLs selected? Why 8? Line 207: What text message was featured on the HWL for each harm? Please provide in the main text of the paper. Line 312: If participants did not open any of the emails in the follow-up period but completed the follow survey, they were still included in the “low dose” group in the analyses? Why was 6 days selected as the cut off? Would participants exposed to 0 image emails in follow be different than participants who were exposed to 5 image emails? Was this decision driven by the data? I now see this is tested in the sensitivity analyses, but I wonder if a very brief explanation could be provided earlier? Discussion Line 442: Please provide an explanation and describe the research and policy implications for high dose exposure resulting in greater negative emotional arousal for the Text + Photograph HWL vs Text-only HWL condition. For example, consistent with evidence of effective labels for both tobacco and alcohol, the photograph HWL may draw consumer attention to key messages and support greater cognitive processing over time. This is important to consider as deep engagement with labels has been shown to be the strongest predictor of motivating consumers to change their behaviour. Therefore, it is critical for more evidence including a post-follow up component as you have in your study (vs. only including an immediate response to labels). I have provided below examples of references to consider. Brewer et al. (2019). Understanding why pictorial pack warnings increase quit attempts. Annals of Behavioral Medicine, 53:232-243. Hammond, D. (2011). Health warning messages on tobacco products: a review. Tobacco Control, 20:327-337. Hobin et al. (2020). Effects of strengthening alcohol labels on attention, message processing, and perceived effectiveness: A quasi-experimental study in Yukon, Canada. International Journal of Drug Policy, 77. Lines 470-471: Please add a statement about current labels being poorly designed in terms of position on container, size, use of colour or border, etc. For example, please consider: “…, where drinkers are exposed to either no HWL or a poorly designed, text-only warning about a limited range of topics that is relatively small in size.” A final suggestion for the discussion is to highlight evidence demonstrating the effectiveness of health warning messages (‘why to reduce’) in combination with drinking guidelines (how to reduce) to encourage drinkers to attempt to reduce their alcohol consumption, and encourage future research to test this label message combination. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Testing the effectiveness of alcohol health warning label formats: An online experimental study with Australian adult drinkers PONE-D-21-36330R1 Dear Dr. Brennan, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Rafael Aiello Bomfim, Phd Academic Editor PLOS ONE Additional Editor Comments (optional): Congratulations Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .